Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

79 trials

NCT07301164
Recruiting
Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases
Early phase 1 · China · 1 site
Registry update: 23 Sept 2026
NCT07305116
Recruiting
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
Phase 1 · China · 1 site
Registry update: 3 Feb 2026
NCT07236762
Recruiting
An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Phase 1 · China · 1 site
Registry update: 4 Mar 2026
NCT07077304
Recruiting
EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
Not applicable · France · 1 site
Registry update: 5 Jun 2026
NCT07236801
Recruiting
Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
Phase 1 · China · 1 site
Registry update: 2 Mar 2026
NCT07168161
Recruiting
BDB-001 Phase III Trial in ANCA-Associated Vasculitis
Phase 3 · China · 64 sites
Registry update: 13 Aug 2026
NCT06983821
Recruiting
Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)
Phase 3 · Canada · 2 sites
Registry update: 30 Jan 2026
NCT07010250
Recruiting
Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
Not applicable · France · 1 site
Registry update: 30 Jun 2026
NCT07151521
Recruiting
(68)Ga-FAPI PET/CT in Patients With ANCA-associated Vasculitis
Not applicable · China · 1 site
Registry update: 17 Nov 2025
NCT07123519
Recruiting
A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
Phase 1 · China · 1 site
Registry update: 21 Oct 2026
NCT07104721
Recruiting
A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Phase 1 · China · 1 site
Registry update: 21 Oct 2026
NCT07203404
Recruiting
A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.
Early phase 1 · China · 1 site
Registry update: 3 Aug 2026
NCT06828042
Recruiting
Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
Phase 1/2 · China · 1 site
Registry update: 22 Sept 2026
NCT04871191
Recruiting
Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
Phase 3 · France · 1 site
Registry update: 3 Apr 2026
NCT07275190
Recruiting
The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome
Not applicable · Italy · 1 site
Registry update: 10 Dec 2025
NCT06980597
Recruiting
A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases
Phase 1 · China · 2 sites
Registry update: 20 May 2025
NCT06978647
Recruiting
A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
Phase 1 · China · 1 site
Registry update: 21 Oct 2026
NCT06512883
Recruiting
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
Phase 3 · Brazil, Canada, France, Israel, India, Mexico, Netherlands, Poland, United States · 15 sites
Registry update: 28 Oct 2026
NCT07150000
Recruiting
Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Not applicable · Germany · 1 site
Registry update: 2 Sept 2025
NCT06941129
Recruiting
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases
Phase 1 · China · 1 site
Registry update: 29 Sept 2025

Ordered by registry start date. Freshness and sponsorship never change the order.